Dark
Light
System
Institutional Investment Manager
CASDIN CAPITAL, LLC
CASDIN CAPITAL, LLC (CIK: 0001534261). Institutional holdings reported to the SEC.

Institutional Holdings (2016Q2)
Portfolio Summary: 27 holdings with a total value of $100,465,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 SPARK THERAPEUTICS INC 162,500 8,309,000 8.27%
2 AGIOS PHARMACEUTICALS INC 187,500 7,855,000 7.82%
3 FOUNDATION MEDICINE INC COM 390,000 7,277,000 7.24%
4 GLOBAL BLOOD THERAPEUTICS IN COM 430,000 7,134,000 7.10%
5 LOXO ONCOLOGY INC COM 300,000 6,954,000 6.92%
6 BLUEPRINT MEDICINES CORP COM 340,000 6,885,000 6.85%
7 SAGE THERAPEUTICS 228,500 6,885,000 6.85%
8 BLUEBIRD BIO INCORPORATED 122,500 5,303,000 5.28%
9 Evolent Health, Inc. 239,500 4,598,000 4.58%
10 ALNYLAM PHARMACEUTICALS INC 72,500 4,023,000 4.00%
11 KITE PHARMA INCORPORATED 72,500 3,625,000 3.61%
12 GENMARK DIAGNOSTICS INC COM 415,000 3,611,000 3.59%
13 VOYAGER THERAPEUTICS INC 322,500 3,544,000 3.53%
14 EPIZYME INC COM 340,000 3,482,000 3.47%
15 CYTOMX THERAPEUTICS INC COM 234,179 2,392,000 2.38%
16 MYOKARDIA INC 179,029 2,220,000 2.21%
17 CLOVIS ONCOLOGY INC 150,000 2,058,000 2.05%
18 IGNYTA INC COM 375,000 2,033,000 2.02%
19 SAGE THERAPEUTICS 65,000 1,958,000 1.95% Call
20 AVEXIS INC COM 45,000 1,711,000 1.70%
21 TESARO INC 20,000 1,681,000 1.67%
22 SPDR SER TR 30,000 1,622,000 1.61% Put
23 BRISTOL MYERS SQUIBB CO 21,000 1,545,000 1.54%
24 DEXCOM 15,000 1,190,000 1.18% Put
25 DEXCOM 15,000 1,190,000 1.18%
26 SYROS PHARMACEUTICALS INC 50,000 908,000 0.90%
27 MEDGENICS INC 85,000 472,000 0.47%

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003861, filed 2016.08.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.